Maximizing the power conversion efficiency (PCE) of perovskite/silicon tandem solar cells that can exceed the Shockley-Queisser single-cell limit requires a high-performing, stable perovskite top cell with a wide bandgap. We developed a stable perovskite solar cell with a bandgap of ~1.7 electron volts that retained more than 80% of its initial PCE of 20.7% after 1000 hours of continuous illumination. Anion engineering of phenethylammonium-based two-dimensional (2D) additives was critical for controlling the structural and electrical properties of the 2D passivation layers based on a lead iodide framework. The high PCE of 26.7% of a monolithic two-terminal wide-bandgap perovskite/silicon tandem solar cell was made possible by the ideal combination of spectral responses of the top and bottom cells.
Using in situ electrical biasing transmission electron microscopy, structural and chemical modification to n-i-p-type MAPbI solar cells are examined with a TiO electron-transporting layer caused by bias in the absence of other stimuli known to affect the physical integrity of MAPbI such as moisture, oxygen, light, and thermal stress. Electron energy loss spectroscopy (EELS) measurements reveal that oxygen ions are released from the TiO and migrate into the MAPbI under a forward bias. The injection of oxygen is accompanied by significant structural transformation; a single-crystalline MAPbI grain becomes amorphous with the appearance of PbI . Withdrawal of oxygen back to the TiO , and some restoration of the crystallinity of the MAPbI , is observed after the storage in dark under no bias. A subsequent application of a reverse bias further removes more oxygen ions from the MAPbI . Light current-voltage measurements of perovskite solar cells exhibit poorer performance after elongated forward biasing; recovery of the performance, though not complete, is achieved by subsequently applying a negative bias. The results indicate negative impacts on the device performance caused by the oxygen migration to the MAPbI under a forward bias. This study identifies a new degradation mechanism intrinsic to n-i-p MAPbI devices with TiO .
Fusion genes represent an important class of biomarkers and therapeutic targets in cancer. ChimerDB is a comprehensive database of fusion genes encompassing analysis of deep sequencing data (ChimerSeq) and text mining of publications (ChimerPub) with extensive manual annotations (ChimerKB). In this update, we present all three modules substantially enhanced by incorporating the recent flood of deep sequencing data and related publications. ChimerSeq now covers all 10 565 patients in the TCGA project, with compilation of computational results from two reliable programs of STAR-Fusion and FusionScan with several public resources. In sum, ChimerSeq includes 65 945 fusion candidates, 21 106 of which were predicted by multiple programs (ChimerSeq-Plus). ChimerPub has been upgraded by applying a deep learning method for text mining followed by extensive manual curation, which yielded 1257 fusion genes including 777 cases with experimental supports (ChimerPub-Plus). ChimerKB includes 1597 fusion genes with publication support, experimental evidences and breakpoint information. Importantly, we implemented several new features to aid estimation of functional significance, including the fusion structure viewer with domain information, gene expression plot of fusion positive versus negative patients and a STRING network viewer. The user interface also was greatly enhanced by applying responsive web design. ChimerDB 4.0 is available at http://www.kobic.re.kr/chimerdb/.
The solution process is the most widely used method to prepare perovskite absorbers for high performance solar cells due to its ease for fabrication and low capital cost.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.